Wernau Asset Management’s AbbVie ABBV Stock Holding History

Wernau Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$323K	Buy	1,283 +28	+2%	+$6.02K	0.17%	40
2026 Q1	$273K	Buy	1,255 +17	+1%	+$3.77K	0.19%	41
2025 Q4	$283K	Buy	1,238 +26	+2%	+$5.92K	0.15%	42
2025 Q3	$281K	Hold	1,212	–	–	0.19%	43
2025 Q2	$225K	Sell	1,212 -261	-18%	-$48.5K	0.16%	43
2025 Q1	$309K	Sell	1,473 -15	-1%	-$2.92K	0.24%	43
2024 Q4	$264K	Buy	+1,488	New	+$274K	0.2%	44

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wernau Asset Management's ABBV Position: Q2 2026 in Review

Wernau Asset Management increased its AbbVie (ABBV) stake by 2.2% in Q2 2026, buying an estimated $6.02K and bringing the position to 1,283 shares worth $323K. The position accounts for 0.17% of the portfolio, ranked #40.

Wernau Asset Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,222 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Wernau Asset Management held 1,283 shares of AbbVie worth $323K as of Q2 2026.
Wernau Asset Management bought 28 AbbVie shares in Q2 2026, an estimated $6.02K.
AbbVie made up 0.17% of Wernau Asset Management's portfolio in Q2 2026, its #40 holding.
Wernau Asset Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,222 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Wernau Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.